Welichem Biotech Inc.

December 19, 2005
Welichem Anounces Management and Board Changes More...
November 23, 2005
Welichem announces resignation of Jianxiong Li as vice president More...
November 10, 2005
Welichem announces new initiatives with its Chinese strategic partners More...
October 17, 2005
Internationally Recognized Cancer Researcher Joins Welichem's Scientific/Clinical Advisory Boards More...
October 05, 2005
Welichem Biotech Inc. appoints Mr. Dan London as Chief Operating Officer More...
September 23, 2005
Welichem Reports Positive Results with its lead Cancer Agent More.
September 22, 2005
Welichem Biotech Inc. Successfully Completes First Annual and Special General Meeting More.
September 19, 2005
Welichem Biotech Inc. granted Australian Patent for compounds treating autoimmune/inflammatory diseases More.
August 18, 2005
Welichem Biotech Inc. announces changes to Board of Directors More.
July 21, 2005
Welichem Biotech Inc. Grants Stock Options More.
July 7, 2005
Welichem Biotech Inc. announces changes to Board of Directors More.
June 7, 2005
Welichem Biotech Inc. completes $1.95 million private placement More.
May 24, 2005
Welichem Commences trading on TSX-V effective May 25, 2005 More.